Company | Date | Price Target | Rating | Analyst |
---|---|---|---|---|
9/10/2024 | $23.80 | Buy | Citigroup | |
8/27/2024 | Buy → Neutral | Goldman | ||
8/27/2024 | $194.00 → $120.00 | Buy → Neutral | Citigroup | |
8/26/2024 | Outperform → Neutral | Macquarie | ||
8/26/2024 | $193.00 → $151.00 | Buy | Jefferies | |
8/23/2024 | $130.00 → $97.00 | Outperform → Mkt Perform | Bernstein | |
8/23/2024 | Buy → Hold | The Benchmark Company | ||
8/23/2024 | $14.00 → $19.00 | Equal Weight → Overweight | Barclays |
BeiGene, Ltd. (NASDAQ:BGNE, HKEX: 06160, SSE: 688235))), a global oncology company, today announced the appointment of Matt Shaulis as General Manager of North America, effective September 25. "We are excited to welcome Matt, who brings a wealth of global pharmaceutical experience, including leading the commercialization of blockbuster franchises at multiple multinational companies," said John V. Oyler, Co-Founder, Chairman and CEO at BeiGene. "Matt's management will be pivotal as we continue our leadership in hematology with BRUKINSA and replicate that success in solid tumors, with a deep and exciting pipeline of innovative therapies." Mr. Shaulis is a global commercial executive with ov
SINGAPORE, Aug. 03, 2024 (GLOBE NEWSWIRE) -- JOYY Inc. (NASDAQ:YY) ("JOYY" or the "Company"), a global technology company, today announced that its board of directors (the "Board") has approved a carefully planned leadership succession. Ms. Ting Li, currently Director and Chief Operating Officer of the Company, will succeed Mr. David Xueling Li as Chairperson of the Board ("Chairperson") and Chief Executive Officer ("CEO"), effective immediately. Mr. David Xueling Li will continue serving as a member of the Board, ensuring continuity and supporting ongoing business momentum. Mr. David Xueling Li stated, "JOYY has become highly globalized, cultivating an engaging and vibrant user community
BeiGene, Ltd. (NASDAQ:BGNE, HKEX: 06160, SSE: 688235))), a global oncology company, today announced the appointment of Aaron Rosenberg as Chief Financial Officer, effective July 22. Mr. Rosenberg will succeed Julia Wang, who is departing to pursue external opportunities and will stay with the Company through August to support the transition. "We are thrilled to welcome Aaron amid a transformational year for BeiGene as we became a top 15 global oncology innovator by revenue with sustained progress to profitability and one of the most prolific and innovative pipelines in our industry including a plan to have at least 10 new molecular entities this year. Aaron's financial leadership and impr
SC 13G/A - Dada Nexus Ltd (0001793862) (Subject)
SC 13D/A - Dada Nexus Ltd (0001793862) (Subject)
SC 13D/A - Lufax Holding Ltd (0001816007) (Subject)
6-K - Dada Nexus Ltd (0001793862) (Filer)
6-K - KE Holdings Inc. (0001809587) (Filer)
6-K - Alibaba Group Holding Ltd (0001577552) (Filer)
SINGAPORE, Aug. 28, 2024 (GLOBE NEWSWIRE) -- JOYY Inc. (NASDAQ:YY) ("JOYY" or the "Company"), a global technology company, today announced its unaudited financial results for the second quarter of 2024. Second Quarter 2024 Financial Highlights1 Net revenues were US$565.1 million, compared to US$547.3 million in the corresponding period of 2023.Net income attributable to controlling interest of JOYY2 was US$52.1 million, compared to US$155.1 million in the corresponding period of 2023.Non-GAAP net income attributable to controlling interest and common shareholders of JOYY3 was US$74.0 million, compared to US$97.3 million in the corresponding period of 2023. Second Quarter 2024 Oper
DUBLIN and SHANGHAI, Aug. 26, 2024 (GLOBE NEWSWIRE) -- PDD Holdings Inc. ("PDD Holdings" or the "Company") (NASDAQ:PDD), today announced its unaudited financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Highlights Total revenues in the quarter were RMB97,059.5 million (US$113,355.8 million), an increase of 86% from RMB52,280.7 million in the same quarter of 2023.Operating profit in the quarter was RMB32,564.5 million (US$4,481.0 million), an increase of 156% from RMB12,718.8 million in the same quarter of 2023. Non-GAAP2 operating profit in the quarter was RMB34,987.3 million (US$4,814.4 million), an increase of 139% from RMB14,609.4 mill
SHANGHAI, China, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Bilibili Inc. ("Bilibili" or the "Company") (NASDAQ:BILI), an iconic brand and a leading video community for young generations in China, today announced its unaudited financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Highlights: Total net revenues were RMB6.13 billion (US$843.1 million), representing an increase of 16% year over year. Advertising revenues were RMB2.04 billion (US$280.4 million), representing an increase of 30% year over year.Mobile games revenues were RMB1.01 billion (US$138.6 million), representing an increase of 13% year over year. Gross profit was RMB1.83 billion (US$252.3 milli
The People’s Bank of China (PBOC) has executed an unscheduled lending operation at significantly lower rates, indicating a potential increase in monetary stimulus to support the economy. What Happened: The PBOC conducted a medium-term lending facility (MLF) operation, issuing 200 billion yuan ($27.5 billion) in one-year loans at a rate of 2.30%, a 20 basis point decrease from the previous MLF loan, Reuters reported. This move follows the bank’s decision to cut several benchmark lending rates just days after a key leadership meeting that outlined major reforms. The central bank also injected 235.1 billion yuan into the market through seven-day reverse repos at 1.70%. This cash injection
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. Below are some instances of options activity happening in the Consumer Discretionary sector: Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume BABA CALL TRADE BULLISH 08/02/24 $79.00 $27.0K 2.4K 1.7K SBUX CALL TRADE B
BEIJING, Sept. 13, 2024 /PRNewswire/ -- iQIYI, China's leading online entertainment platform, has sparked a fresh surge of enthusiasm for stand-up comedy with the launch of its original show, The King of Stand-up Comedy. The show has quickly gained acclaim and generated widespread social buzz since its debut, highlighting iQIYI's commitment to producing high-quality comedy content. In addition to discovering new creative talent, the show has seamlessly integrated online and offline markets, fostering sustainable growth in the domestic comedy industry. Initiated by the legendary Hong Kong film star and director Stephen Chow, the show features 44 groups of comedians vying for the coveted title
Singapore Kicks Off the First Stop of TME's Music Journey to the World SHENZHEN, China, Sept. 12, 2024 /PRNewswire/ -- On September 11, 2024, Tencent Music Entertainment Group (TME) announced the launch of its Global Music Outreach Initiative, which will bring together talented Chinese music artists and their works to be showcased on prominent stages worldwide. The initiative will kickstart in Singapore from September 13 to 17, beginning a broader series of music and industry exchange activities around the world, including overseas performances, international music creation exchanges, and discussions on future industry development. As Chinese culture continues to capture global attention, TM
BeiGene, Ltd. (NASDAQ:BGNE, HKEX: 06160, SSE: 688235))), a global oncology company, today announced the appointment of Matt Shaulis as General Manager of North America, effective September 25. "We are excited to welcome Matt, who brings a wealth of global pharmaceutical experience, including leading the commercialization of blockbuster franchises at multiple multinational companies," said John V. Oyler, Co-Founder, Chairman and CEO at BeiGene. "Matt's management will be pivotal as we continue our leadership in hematology with BRUKINSA and replicate that success in solid tumors, with a deep and exciting pipeline of innovative therapies." Mr. Shaulis is a global commercial executive with ov
Citigroup resumed coverage of KE Holdings with a rating of Buy and set a new price target of $23.80
Goldman downgraded iQIYI from Buy to Neutral
Citigroup downgraded Pinduoduo from Buy to Neutral and set a new price target of $120.00 from $194.00 previously
4 - BeiGene, Ltd. (0001651308) (Issuer)
4 - BeiGene, Ltd. (0001651308) (Issuer)
4 - BeiGene, Ltd. (0001651308) (Issuer)